Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT02084342 Active, not recruiting - Clinical trials for Idiopathic Scoliosis

Study of DDAVP Combined With TXA on the Blood Loss and Transfusion Need During and After Scoliosis Correction Surgery

Start date: December 2013
Phase: N/A
Study type: Interventional

Intraoperative administration of tranexamic acid (TXA,T) reduces significantly blood loss and blood transfusion requirements during spinal posterior fusion in adolescents with scoliosis. TXA acts mainly by inhibit the plasminogen activator. Desmopressin (DDAVP ,D) can inhibit the fibrinolytic activity by inducing the release of von Willebrand factor from the endothelial cells. But at the same time, it releases tissue-type plasminogen activator (t-PA), which may cripple its hemostatic effect. The investigators supposed that if the investigators combine TXA with DDAVP in scoliosis correction surgery, the blood loss and the transfusion need would be reduced significantly.

NCT ID: NCT02080494 Active, not recruiting - Surgery Clinical Trials

Tranexamic Acid in Orthopaedic Trauma Surgery

Start date: May 2012
Phase: N/A
Study type: Interventional

Tranexamic acid is an antifibrinolytic drug that has been used to decrease post-operative blood loss. This study is a prospective, randomized controlled trial investigating the use of tranexamic acid in fracture surgery around the hip and knee, in which significant blood loss (>300mL) is expected. The hypothesis of this study is that tranexamic acid will be associated with a decrease in post-operative blood loss, as well as a decreased need for allogenic blood transfusion, in patients who have fracture surgery around the hip and knee.

NCT ID: NCT02076373 Active, not recruiting - Clinical trials for Intraventricular Hemorrhage of Prematurity

Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants

EpoRepair
Start date: March 2014
Phase: Phase 3
Study type: Interventional

The purpose of this randomized and placebo-controlled EpoRepair trial is to evaluate the effect of intravenously administered recombinant human erythropoietin (Epo) as compared to placebo in preterm infants with brain damage on neurological development until five years od age.

NCT ID: NCT02056769 Active, not recruiting - Clinical trials for Subarachnoid Hemorrhage

CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage

CT-PIPS
Start date: April 2014
Phase: N/A
Study type: Interventional

Patients with brain hemorrhage resulting from a ruptured aneurysm (SAH) are at risk of developing a condition called vasospasm, one or two weeks after their hemorrhage. This is a major cause of stroke and death following SAH. A special type of CT scan, called CT perfusion, analyzes regional blood flow in the brain. We hypothesize that CT perfusion scans performed on admission and day 6 post-hemorrhage will enable us to predict which patients will go on to develop vasospasm.

NCT ID: NCT02002260 Active, not recruiting - Clinical trials for Abnormal Uterine Bleeding

Stopping Heavy Periods Project

SHiPP
Start date: February 2013
Phase: N/A
Study type: Interventional

This study is a randomized clinical trial comparing the effectiveness of the levonorgestrel intrauterine system (LNG-IUS) to combined oral contraceptives (COCs) for improving quality of life among women who report heavy menstrual bleeding.

NCT ID: NCT01992991 Active, not recruiting - Clinical trials for Cerebrovascular Disorders

Transcranial Stimulation for Upper Limb Training of Individuals With Sequelae From Intracranial Hemorrhage

tDCS-ICH
Start date: December 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of transcranial stimulation for upper limb training of patients with sequelae from an intracranial hemorrhage. Patients receive five days of upper limb occupational therapy training in combination with real or sham stimulation. Patients complete the Jebsen Taylor Hand Function Test before, after and 7 days later. The intervention takes place at patients' home address.

NCT ID: NCT01947361 Active, not recruiting - Stroke Clinical Trials

Heart Rate and Initial Presentation of Cardiovascular Diseases (Caliber)

Start date: January 2012
Phase: N/A
Study type: Observational

Study of heterogeneity in associations between heart rate and the initial presentation of 12 cardiovascular diseases.

NCT ID: NCT01937065 Active, not recruiting - Stroke Clinical Trials

Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER Study

IP4
Start date: January 2012
Phase: N/A
Study type: Observational

Study of heterogeneity in associations between social deprivation and the initial presentation of 12 cardiovascular diseases.

NCT ID: NCT01856699 Active, not recruiting - Ischemic Stroke Clinical Trials

Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy

SuSPect-CAA
Start date: May 2013
Phase: N/A
Study type: Observational

Aim of the SuSPect-CAA study is to prospectively evaluate the prognostic significance of cortical superficial siderosis in patients with suspected cerebral amyloid angiopathy with a primary focus on future stroke and mortality.

NCT ID: NCT01623180 Active, not recruiting - Bleeding Clinical Trials

A Randomized Clinical Evaluation of the BioFreedomâ„¢ Stent

Leaders Free
Start date: December 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate that a BioFreedomâ„¢ Drug Coated Stent is non-inferior to a bare metal stent at one year as measured by the composite safety endpoint of cardiovascular death, myocardial infarction and definite/probable stent thrombosis, and that its efficacy is superior to a bare metal stent as measured by clinically driven TLR at one year.